← Open Payments lookup

MICHAEL WISHER: Open Payments

NPI 1467454942 · HAUPPAUGE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,123 in 177 payments from 13 companies in 2025. Trend: 2023 $2,623 · 2024 $3,112 · 2025 $4,123

Food & beverage: $4,123
CompanyPaymentsAmount
ABBVIE INC.30$696
Alkermes, Inc.22$693
Neurocrine BioSciences, Inc.29$601
Otsuka America Pharmaceutical, Inc.18$502
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$389
Axsome Therapeutics, Inc.11$309
Lundbeck LLC19$292
E.R. Squibb & Sons, L.L.C.8$221
Takeda Pharmaceuticals U.S.A., Inc.8$189
Corium, LLC5$93

Products named: REXULTI, VRAYLAR, INGREZZA, ARISTADA, CAPLYTA, Auvelity, COBENFY, TRINTELLIX.

Industry payments across NY — which companies pay providers there.